Misconduct Case

In the article on the misconduct case at the Fox Chase Cancer Center (FCCC) (B. Goodman, The Scientist, Aug. 18, 1997, page 1), Patricia Harsche, a center official, in commenting on why no conclusion of fraud was made by the FCCC investigating committee, stated that they "have expertise that [Jerome] Freed and [Faith] Fenderson do not have." Actually, the only expertise required to find the falsification at issue was the knowledge of how to use a computer spreadsheet. The FCCC committee conclud

Written byJerome Freed
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

In the article on the misconduct case at the Fox Chase Cancer Center (FCCC) (B. Goodman, The Scientist, Aug. 18, 1997, page 1), Patricia Harsche, a center official, in commenting on why no conclusion of fraud was made by the FCCC investigating committee, stated that they "have expertise that [Jerome] Freed and [Faith] Fenderson do not have." Actually, the only expertise required to find the falsification at issue was the knowledge of how to use a computer spreadsheet.

The FCCC committee concluded that there were reasonable alternative explanations other than fraud for the changes in the files that they, confirming the work already carried out by the Office of Research Integrity (ORI), had also found. But it must be noted that the committee's final report (dated Aug. 31, 1995) does not indicate what these explanations might have been. Their report indicates clearly that they found "cooked" spreadsheets, that is, definitive ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies